SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041719
Filing Date
2019-11-07
Accepted
2019-11-07 16:06:34
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20190930.htm 10-Q 2250167
2 EX-10.1 sndx-ex101_184.htm EX-10.1 74785
3 EX-10.2 sndx-ex102_185.htm EX-10.2 17565
4 EX-31.1 sndx-ex311_8.htm EX-31.1 10283
5 EX-31.2 sndx-ex312_6.htm EX-31.2 10736
6 EX-32.1 sndx-ex321_7.htm EX-32.1 11887
  Complete submission text file 0001564590-19-041719.txt   8719406

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sndx-20190930.xml EX-101.INS 2277772
8 XBRL TAXONOMY EXTENSION SCHEMA sndx-20190930.xsd EX-101.SCH 53173
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20190930_cal.xml EX-101.CAL 45976
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20190930_def.xml EX-101.DEF 168463
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20190930_lab.xml EX-101.LAB 377772
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20190930_pre.xml EX-101.PRE 282181
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 191200311
SIC: 2834 Pharmaceutical Preparations